Literature DB >> 4428453

Cardiorespiratory effects of protamine after cardiopulmonary bypass in man.

J Jastrzebski, M K Sykes, D G Woods.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4428453      PMCID: PMC470194          DOI: 10.1136/thx.29.5.534

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  17 in total

1.  Assessment of damage to human platelets after aggregation and other injuries by microscopic observation and estimation of serotonin uptake.

Authors:  G Zbinden; J N Mehrishi; S Tomlin
Journal:  Thromb Diath Haemorrh       Date:  1970-05-31

2.  Platelet surface charge and aggregation. Effects of polyelectrolytes.

Authors:  K A Gröttum
Journal:  Thromb Diath Haemorrh       Date:  1969-06-15

3.  A mixing device for expired gas.

Authors:  M K Sykes
Journal:  Anaesthesia       Date:  1968-07       Impact factor: 6.955

4.  The effect of variations in end-expiratory inflation pressure on cardiorespiratory function before and after open-heart surgery.

Authors:  R F Seed; M K Sykes; W E Finlay
Journal:  Br J Anaesth       Date:  1970-06       Impact factor: 9.166

5.  Cardiovascular effects of protamine sulfate.

Authors:  B S Goldman; J Joison; W G Austen
Journal:  Ann Thorac Surg       Date:  1969-05       Impact factor: 4.330

6.  Must heparin be neutralized following open-heart operations?

Authors:  A R Castaneda
Journal:  J Thorac Cardiovasc Surg       Date:  1966-11       Impact factor: 5.209

7.  Blood gas calculator.

Authors:  J W Severinghaus
Journal:  J Appl Physiol       Date:  1966-05       Impact factor: 3.531

8.  The elimination of carbon dioxide after total body perfusion.

Authors:  A Pauca; M K Sykes
Journal:  Br J Anaesth       Date:  1966-01       Impact factor: 9.166

9.  Heparin neutralization: experimental and clinical studies.

Authors:  A R Castaneda; H Gans; K C Weber; I J Fox
Journal:  Surgery       Date:  1967-10       Impact factor: 3.982

10.  Effect of bypass surgery on coagulation-sensitive clotting factors.

Authors:  J E Woods; J W Kirklin; C A Owen; J H Thompson; H F Taswell
Journal:  Mayo Clin Proc       Date:  1967-11       Impact factor: 7.616

View more
  9 in total

1.  Increased pulmonary artery diastolic-pulmonary wedge pressure gradient after cardiopulmonary bypass.

Authors:  J Heinonen; M Salmenperä; O Takkunen
Journal:  Can Anaesth Soc J       Date:  1985-03

2.  The beneficial effects of aminophylline administration on heparin reversal with protamine.

Authors:  S F Katircioglu; D S Küçükaksu; M Bozdayi; K Dalva; B Mavitaş; Y Zorlutuna; O Taşdemir; K Bayazit
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

3.  Complement and the damaging effects of cardiopulmonary bypass.

Authors:  S Westaby
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

4.  Protamine induced arterial hypoxaemia: the relationship to hypoxic pulmonary vasoconstriction.

Authors:  Y D Kim; R Michalik; D E Lees; M Jones; S Hanowell; T E Macnamara
Journal:  Can Anaesth Soc J       Date:  1985-01

5.  The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.

Authors:  B Milne; K Rogers; F Cervenko; T Salerno
Journal:  Can Anaesth Soc J       Date:  1983-07

6.  Cardiac arrest following protamine administration.

Authors:  F Chung; J Miles
Journal:  Can Anaesth Soc J       Date:  1984-05

7.  Complement activation and anaphylactoid response to protamine in a child after cardiopulmonary bypass.

Authors:  S Westaby; M W Turner; J Stark
Journal:  Br Heart J       Date:  1985-05

8.  Effect of Lidocaine Pre-Treatment on Protamine-Induced Pulmonary Vascular Reaction During the Repair of Congenital Heart Disease.

Authors:  Hong-Wu Wang; Yi-Jin Hu; Guo-Lin Wang
Journal:  Int J Gen Med       Date:  2021-06-03

9.  Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Piotr Podlasz; Małgorzata Chmielewska-Krzesińska; Miłosz Zajączkowski; Adam Kosiński; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.